COVID-19 Therapeutics

Access resources related to COVID-10 therapeutics and other procedures shared by children's hospitals.

Resources

Announcement or News
Emergency Use Authorization for Bamlanivimab
November 13, 2020

Bamlanivimab is now authorized for the treatment of mild to moderate COVID-19 in outpatient adults and pediatric patients 12 years and older weighing more than 88 pounds (40 kg) with a positive COVID-19 test.

Announcement or News
Bamlanivimab Allocation Dashboard
November 13, 2020

This dashboard will be updated each distribution week until the FDA issues a revised EUA indicating the U.S. government involvement in the allocation and distribution process is no longer needed.

Announcement or News
Lilly Bamlanivimab Antibody Playbook
November 13, 2020

This Antibody Playbook provides information for state, territorial and local public health programs to plan and operationalize a bamlanivimab antibody response to COVID-19.